Showing results (11-20 of 263) with videos related to
Sort By:
Pageof 27
The Hematology Journal : the Official Journal of the European Haematology Association|April 18, 2002
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trialAmine Belhabri, Xavier Thomas, Eric Wattel, et al.Hematology (Amsterdam, Netherlands)|June 19, 2010
A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 scheduleOlfa Derbel, Giovanna Cannas, Quoc-Hung Le, et al.Hematology (Amsterdam, Netherlands)|February 28, 2007
Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experienceAnne-Sophie Michallet, Youcef Chelghoum, Anne Thiebaut, et al.Cancer|May 25, 2005
Acute leukemia during pregnancy: a report on 37 patients and a review of the literatureYoucef Chelghoum, Norbert Vey, Emmanuel Raffoux, et al.Cancer|June 30, 2012
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patientsMauricette Michallet, Karine Goldet, Mohamad Sobh, et al.Blood|June 22, 2011
Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 studyXavier Thomas, Mohamed Elhamri, Emmanuel Raffoux, et al.Leukemia Research|June 1, 2012
Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trialXavier Thomas, Emmanuel Raffoux, Aline Renneville, et al.World Journal of Stem Cells|January 12, 2018
High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemiaAdriana Plesa, Charles Dumontet, Eve Mattei, et al.Current Oncology Reports|April 28, 2025
Rare Genetic and Uncommon Morphological Entities in Adults with Acute Myeloid LeukemiaXavier ThomasExpert Opinion on Drug Metabolism & Toxicology|July 10, 2008
New emerging applications of molgramostim in acute myeloid leukaemiaXavier ThomasPageof 27